Korean Guidelines for Postpolypectomy Colonoscopic Surveillance : 2022 Revised Edition
Colonoscopic polypectomy is effective in decreasing the incidence and mortality of colorectal cancer (CRC). Premalignant polyps discovered during colonoscopy are associated with the risk of metachronous advanced neoplasia. Postpolypectomy surveillance is the most important method for managing advanced metachronous neoplasia. A more efficient and evidence-based guideline for postpolypectomy surveillance is required because of the limited medical resources and concerns regarding colonoscopy complications. In these consensus guidelines, an analytic approach was used to address all reliable evidence to interpret the predictors of CRC or advanced neoplasia during surveillance colonoscopy. The key recommendations state that the high-risk findings for metachronous CRC following polypectomy are as follows: 1) adenoma ≥10 mm in size; 2) 3-5 (or more) adenomas; 3) tubulovillous or villous adenoma; 4) adenoma containing high-grade dysplasia; 5) traditional serrated adenoma; 6) sessile serrated lesion (SSL) containing any grade of dysplasia; 7) serrated polyp of at least 10 mm in size; and 8) 3-5 (or more) SSLs. More studies are needed to fully comprehend the patients who are most likely to benefit from surveillance colonoscopy and the ideal surveillance interval to prevent metachronous CRC.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:80 |
---|---|
Enthalten in: |
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi - 80(2022), 3 vom: 25. Sept., Seite 115-134 |
Sprache: |
Koreanisch |
---|
Beteiligte Personen: |
Kim, Su Young [VerfasserIn] |
---|
Links: |
---|
Themen: |
Colonoscopy |
---|
Anmerkungen: |
Date Completed 28.09.2022 Date Revised 03.10.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.4166/kjg.2022.103 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM346722926 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM346722926 | ||
003 | DE-627 | ||
005 | 20231226032131.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||kor c | ||
024 | 7 | |a 10.4166/kjg.2022.103 |2 doi | |
028 | 5 | 2 | |a pubmed24n1155.xml |
035 | |a (DE-627)NLM346722926 | ||
035 | |a (NLM)36156035 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a kor | ||
100 | 1 | |a Kim, Su Young |e verfasserin |4 aut | |
245 | 1 | 0 | |a Korean Guidelines for Postpolypectomy Colonoscopic Surveillance |b 2022 Revised Edition |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.09.2022 | ||
500 | |a Date Revised 03.10.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Colonoscopic polypectomy is effective in decreasing the incidence and mortality of colorectal cancer (CRC). Premalignant polyps discovered during colonoscopy are associated with the risk of metachronous advanced neoplasia. Postpolypectomy surveillance is the most important method for managing advanced metachronous neoplasia. A more efficient and evidence-based guideline for postpolypectomy surveillance is required because of the limited medical resources and concerns regarding colonoscopy complications. In these consensus guidelines, an analytic approach was used to address all reliable evidence to interpret the predictors of CRC or advanced neoplasia during surveillance colonoscopy. The key recommendations state that the high-risk findings for metachronous CRC following polypectomy are as follows: 1) adenoma ≥10 mm in size; 2) 3-5 (or more) adenomas; 3) tubulovillous or villous adenoma; 4) adenoma containing high-grade dysplasia; 5) traditional serrated adenoma; 6) sessile serrated lesion (SSL) containing any grade of dysplasia; 7) serrated polyp of at least 10 mm in size; and 8) 3-5 (or more) SSLs. More studies are needed to fully comprehend the patients who are most likely to benefit from surveillance colonoscopy and the ideal surveillance interval to prevent metachronous CRC | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Colonoscopy | |
650 | 4 | |a Colorectal cancer | |
650 | 4 | |a Guideline | |
650 | 4 | |a Polypectomy | |
650 | 4 | |a Surveillance | |
700 | 1 | |a Kwak, Min Seob |e verfasserin |4 aut | |
700 | 1 | |a Yoon, Soon Man |e verfasserin |4 aut | |
700 | 1 | |a Jung, Yunho |e verfasserin |4 aut | |
700 | 1 | |a Kim, Jong Wook |e verfasserin |4 aut | |
700 | 1 | |a Boo, Sun-Jin |e verfasserin |4 aut | |
700 | 1 | |a Oh, Eun Hye |e verfasserin |4 aut | |
700 | 1 | |a Jeon, Seong Ran |e verfasserin |4 aut | |
700 | 1 | |a Nam, Seung-Joo |e verfasserin |4 aut | |
700 | 1 | |a Park, Seon-Young |e verfasserin |4 aut | |
700 | 1 | |a Park, Soo-Kyung |e verfasserin |4 aut | |
700 | 1 | |a Chun, Jaeyoung |e verfasserin |4 aut | |
700 | 1 | |a Baek, Dong Hoon |e verfasserin |4 aut | |
700 | 1 | |a Choi, Mi-Young |e verfasserin |4 aut | |
700 | 1 | |a Park, Suyeon |e verfasserin |4 aut | |
700 | 1 | |a Byeon, Jeong-Sik |e verfasserin |4 aut | |
700 | 1 | |a Kim, Hyung Kil |e verfasserin |4 aut | |
700 | 1 | |a Cho, Joo Young |e verfasserin |4 aut | |
700 | 1 | |a Lee, Moon Sung |e verfasserin |4 aut | |
700 | 1 | |a Lee, Oh Young |e verfasserin |4 aut | |
700 | 0 | |a Korean Society of Gastrointestinal Endoscopy |e verfasserin |4 aut | |
700 | 0 | |a Korean Society of Gastroenterology |e verfasserin |4 aut | |
700 | 0 | |a Korean Association for the Study of Intestinal Diseases |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi |d 2003 |g 80(2022), 3 vom: 25. Sept., Seite 115-134 |w (DE-627)NLM14272808X |x 2233-6869 |7 nnns |
773 | 1 | 8 | |g volume:80 |g year:2022 |g number:3 |g day:25 |g month:09 |g pages:115-134 |
856 | 4 | 0 | |u http://dx.doi.org/10.4166/kjg.2022.103 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 80 |j 2022 |e 3 |b 25 |c 09 |h 115-134 |